These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15093545

  • 1. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.
    Hayakawa F, Privalsky ML.
    Cancer Cell; 2004 Apr; 5(4):389-401. PubMed ID: 15093545
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
    Fasci D, Anania VG, Lill JR, Salvesen GS.
    Sci Signal; 2015 Jun 09; 8(380):ra56. PubMed ID: 26060329
    [Abstract] [Full Text] [Related]

  • 10. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
    Rabellino A, Carter B, Konstantinidou G, Wu SY, Rimessi A, Byers LA, Heymach JV, Girard L, Chiang CM, Teruya-Feldstein J, Scaglioni PP.
    Cancer Res; 2012 May 01; 72(9):2275-84. PubMed ID: 22406621
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure.
    Ablain J, Rice K, Soilihi H, de Reynies A, Minucci S, de Thé H.
    Nat Med; 2014 Feb 01; 20(2):167-74. PubMed ID: 24412926
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia.
    Hong SH, Yang Z, Privalsky ML.
    Mol Cell Biol; 2001 Nov 01; 21(21):7172-82. PubMed ID: 11585900
    [Abstract] [Full Text] [Related]

  • 19. Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.
    Goto E, Tomita A, Hayakawa F, Atsumi A, Kiyoi H, Naoe T.
    Blood; 2011 Aug 11; 118(6):1600-9. PubMed ID: 21613260
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.